Conmed (CNMD) Tops Q1 EPS by 1c, Offers Guidance

Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $181.2 million versus the consensus estimate of $180.62 million.

GUIDANCE:

Conmed sees FY2016 EPS of $1.95-$2.05, versus the consensus of $1.90. Conmed sees FY2016 revenue of $768-778 million, versus the consensus of $765.19 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Reading (RDI) Tops Q2 EPS by 4c